Company Overview and News

 
Too many PSU banks in India; here’s what SBI Chief Rajnish Kumar has to say

2h financialexpress
Amid the on-going merger of first of three public sector banks, State Bank of India (SBI) Rajnish Kumar has said that India has too many PSBs and that the merger process was inevitable. In an interview with ET Now, SBI chief said that 21 PSBs are too many and they needed to be reduced in number echoing the popular opinion.
532121 DENABANK SBAZ 532401 VIJAYABANK

 
New age takeover: Debit card PoS transactions of Airtel, Paytm, Fino Payments banks beat those of mid-sized PSBs!

2018-10-14 financialexpress
The volume of point-of-sale (POS)-based transactions reported by debit card users of three payments banks—Airtel Payments Bank, Fino Payments Bank and Paytm Payments Bank — is now higher than those made by debit card holders of some mid-sized public sector banks (PSBs), data from the Reserve Bank of India (RBI) showed.
532121 UDBKL UBLA UBLS TCHQY DENABANK 532755 TECHM 532401 VIJAYABANK

 
RBI#39;s corrective action on 12 banks limited losses, saved taxpayer money: Viral Acharya

2018-10-12 moneycontrol
Prompt Corrective Action (PCA) imposed on 12 banks has limited their losses and saved taxpayer money, according to the central bank’s Deputy Governor Viral Acharya.
IOB 500116 UDBKL IDBI ALBK UBLS 532505 532179 532388 532121 CRPKY UBLA 532480 CORPBANK UCOBANK DENABANK

 
Dena Bank - Updates

2018-10-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532121 DENABANK

 
Bank of Baroda shares gain over 4% on extension of CEO’s term

2018-10-12 thehindubusinessline
The Bank of Baroda shares are down nearly 42 per cent this year as of Thursday's close.
532121 DENABANK 532401 VIJAYABANK

 
Union Bank of India to raise Rs 700 cr from stake sale in six firms

2018-10-11 financialexpress
Union Bank of India has put up for sale its stakes in six companies to raise around Rs 700 crore, according to a sale document. The public-sector lender has invited bids for its 0.41% stake in National Stock Exchange (NSE), 2.81% each in National Securities Depository (NSDL) and NSDL eGovernance Infrastructure, 1.95% in Small Industries Development Bank of India (Sidbi), 1% in Clearing Corporation of India (CCIL) and 4.
UBNC 500116 PNJZY 532121 532461 532483 IDBI PNB CANBK DENABANK CNRYY

 
ILFS, other NBFCs making timely repayments, says Bank of Baroda chief

2018-10-09 moneycontrol
Bank of Baroda's exposure to Infrastructure Leasing and Financial Services (IL&FS) and non-bank lenders is 'fully performing' currently, even as the debt-strapped company has defaulted on several of its debt obligations.
YESBANK 532121 532648 YYBKY DENABANK 532401 VIJAYABANK

 
Bank of Baroda-Vijaya-Dena merger gets a step closer; board approval done, proposal sent for government nod

2018-10-09 financialexpress
Nearly 20 days after the proposal to merge Bank of Baroda, Vijaya Bank and Dena Bank into India’s third largest bank was made by the Narendra Modi government, the board members of all the three banks have given their approval. The proposal now has been sent to the government for its official approval, news agency PTI reported.
532121 DENABANK SBAZ 532401 VIJAYABANK

 
Bank Unions to protest against PSU banks’ merger decision on Tuesday

2018-10-08 financialexpress
A bank employee unions’ federation has called upon bank unions to hold demonstrations Tuesday to protest against the merger of three state-run lenders –Bank of Baroda, Vijaya Bank and Dena Bank, a union leader said Monday.
532121 DENABANK 532401 VIJAYABANK

 
Punjab National Bank MD rules out acquiring other public sector banks

2018-10-07 financialexpress
Ruling out possibility of inorganic expansion, Punjab National Bank Managing Director Sunil Mehta said the bank is currently focussed on internal consolidation and making it financially healthy. With Rs 14,000 crore Nirav Modi episode getting out of scene, the bank is focussing on growth and recovery of bad loans, he told PTI in an interview. The bank has registered credit growth more than the industry average, and appreciating the pace of recovery, the government has decided to provide Rs 5,431 crore capital support.
532121 DENABANK 532401 VIJAYABANK

1
Chiefs of Dena Bank, Bank of Baroda, Vijaya Bank to meet by 12 Oct over merger

2018-10-03 livemint
Mumbai: The heads of the three state-run banks awaiting merger—Dena Bank, Bank of Baroda (BoB) and Vijaya Bank—will meet by 12 October to plan out its implementation, Dena Bank’s newly-appointed managing director (MD) and CEO Karnam Sekar said.
532121 HDB 500180 HDFCBANK DENABANK SBAZ 532401 VIJAYABANK

 
BoB, Vijaya Bank approve merger proposal to create second largest PSU lender

2018-09-29 moneycontrol
The boards of state-run Bank of Baroda (BoB) and Vijaya Bank on September 29, gave in-principle approvals for their amalgamation with another lender Dena Bank, a move that would create the second-largest entity in the PSU banking space.
532121 DENABANK SBAZ 532401 VIJAYABANK

 
Vijaya Bank board approves merger proposal with Bank of Baroda, Dena Bank

2018-09-29 moneycontrol
The board of state-run Vijaya Bank Saturday gave in-principle approval for its merger with Bank of Baroda along with another PSU lender Dena Bank. Earlier this month, the government announced the merger of Bank of Baroda, Vijaya Bank and Dena Bank to create the country's second-largest PSU lender by assets and branches.
532121 DENABANK SBAZ 532401 VIJAYABANK

 
Vijaya Bank board approves merger proposal with Bank of Baroda, Dena Bank

2018-09-29 financialexpress
The board of state-run Vijaya Bank Saturday gave in-principle approval for its merger with Bank of Baroda along with another PSU lender Dena Bank.
532121 DENABANK SBAZ 532401 VIJAYABANK

 
This week in personal finance: What to do if your fund house suspends fresh subscriptions; how account holders should react to bank mergers

2018-09-29 moneycontrol
The capital market has seen one of the most turbulent periods last week as markets plummeted, eroding investor’s wealth after the IL&FS crisis surfaced. However, during the weeks and months before that, the market had been strong, resulting in huge inflows into mutual funds, some of whom were forced to temporarily suspend subscriptions.
532121 DENABANK 532401 VIJAYABANK

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...